Science & Policy
STAT+: Pharmalittle: We’re reading about concerns over a rare disease drug, pharma payments to docs, and more
Summary: Patient advocates and some experts are expressing growing alarm over the perceived risks of a Neurocrine Biosciences rare disease drug
Patient advocates and some experts are expressing growing alarm over the perceived risks of a Neurocrine Biosciences rare disease drug
Adults 21+. WINDBAR does not sell nicotine products on this site. Compliance statement.